Krystal Biotech Inc (KRYS) — Quality & forensics
As of 2026-10-14 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 16
- Quality 85
- Growth 72
- Balance sheet 96
- Cash quality 38
- Capital allocation 17
- Momentum 68
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the KRYS chart & overview · the earnings record
FAQ · from the current data · as of 2026-10-14
Quick answers
What is Krystal Biotech Inc's Closelooknet quality reading?
The composite reads 61/100 across 7 modules, as of 2026-10-14: valuation 16, quality 85, growth 72, balance sheet 96, cash quality 38, capital allocation 17, momentum 68. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Krystal Biotech Inc's Altman Z-Score?
52.00, which sits in the safe zone (above 2.99) as of 2026-10-14. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Krystal Biotech Inc's Piotroski F-Score?
6 of 8, as of 2026-10-14. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Krystal Biotech Inc's Beneish M-Score indicate?
-2.24 — below the −1.78 manipulation-risk threshold, as of 2026-10-14. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- UCB.BR UCB SAindustry
- PTGX Protagonist Therapeutics Incindustry
- VRTX Vertex Pharmaceuticals Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- EXEL Exelixis Incindustry
- RXRX Recursion Pharmaceuticals Incindustry
- TWST Twist Bioscience Corpindustry
- TECH Bio-Techne Corpindustry
- RPRX Royalty Pharma Plcindustry
- ONC BeiGene, Ltd.industry
- REGN Regeneron Pharmaceuticals Incindustry
- RVMD Revolution Medicines Incindustry
- BION.SW BB Biotech AGindustry
- ROIV Roivant Sciences Ltdindustry